Benzinga's Top Pre-Market Gainers

Endo Pharmaceuticals Holdings Inc

surged 9.53% to $37.25 in the pre-market session. ENDP announced the US Food and Drug Administration (FDA) approval of a new formulation of Opana® ER designed to be crush-resistant. BioSante Pharmaceuticals Inc

moved up 4.08% to $2.55 in the pre-market session. BPAX shares have surged 63.33% over the past 52 weeks, while the S&P 500 index has gained 1.19% in the same period. ARIAD Pharmaceuticals Inc

soared 3.10% to $11.99 in the pre-market trading. ARIA reported preliminary clinical data from the pivotal PACE trial of its investigational pan-BCR-ABL inhibitor, ponatinib. Vodafone Group Plc

added 0.73% to $27.48 in the pre-market session. Vodafone has a dividend yield of 3.60%.